A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin’s lymphoma

Published:2003-02 Issue:2 Volume:14 Page:258-267
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bessell E.M.,Burton A.,Haynes A.P.,Glaholm J.,Child J.A.,Cullen M.H.,Davies J.M.,Smith G.M.,Ellis I.O.,Jack A.,Jones E.L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/14/2/258/361075/mdg067.pdf

Reference25 articles.

1. Non-Hodgkin’s lymphoma in the elderly: a study of 602 patients aged 70 or older from a Danish population-based registry. The Danish LYEO-Study Group;D’Amore;Ann Oncol,1992

2. The National Cancer Data Base report on non-Hodgkin’s lymphoma;Glass;Cancer,1997

3. 2001 Census. Office of Population Censuses and Surveys. London, UK: Her Majesty’s Stationery Office 2002

4. The Non-Hodgkin’s Lymphoma Classification Project. Effect of age on the characteristics and clinical behaviour of non-Hodgkin’s lymphoma patients);Ann Oncol,1997

5. The National Institute on Ageing and the National Cancer Institute SEER collaborative study on co-morbidity and early diagnosis of cancer in the elderly;Havlik;Cancer,1994

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics, treatment patterns and outcomes of patients older than 80 years diagnosed with DLBCL in China over a 10-year period;Cancer Chemotherapy and Pharmacology;2019-05-13

2. Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience;BMC Cancer;2018-10-19

3. Rituximab plus reduced-dose cyclophosphamide, doxorubicin, vincristine and prednisone (RD R-CHOP) chemotherapy is feasible for very elderly patients (≥80 years) with B-cell lymphoma: analysis of treatment outcome;Journal of Chemotherapy;2016-06-17

4. Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification;British Journal of Dermatology;2012-09-05

5. Therapeutic strategies in elderly and very elderly patients;Best Practice & Research Clinical Haematology;2012-03